Latest version of the Koronavilkku app was released 17 June - with instructions for vaccinated people who receive an exposure notification

An updated version of the Koronavilkku application was released on 17 June. The version contains new instructions in accordance with the national coronavirus guidelines for vaccinated persons or those who have had COVID-19 and who have received an exposure notification. An accessibility statement has also been added to the application. 

In addition to general instructions, the application will now provide targeted instructions to persons who have already received one or two vaccine doses or who have had COVID-19. The guidelines take into account the Finnish Institute for Health and Welfare’s changed quarantine practices for asymptomatic persons who have received the vaccine and had COVID-19. For example, asymptomatic persons who have received two doses of the vaccine, and more than a week has elapsed since their last dose, do not need to quarantine after receiving an exposure notification. 

Use of the Koronavilkku application will continue normally after the version update. The changes made to the new update version will only be seen by recipients of exposure notifications. 

On most phones, Koronavilkku updates automatically. However, we recommend that you make sure that the app has been updated. You can check by visiting the app store (Google Play or Apple App Store).
For direct links to app stores and additional information on the app see the Koronavilkku.fi website

The corresponding update for Huawei’s AppGallery will be released later.

Koronavilkku is a convenient and effective way to prevent the spread of coronavirus. In spite of the improved disease figures and the progress of vaccinations, Koronavilkku should still be kept activated. Also, even if you have received one or two doses of the vaccine, you must still get tested if you experience symptoms.  

koronavilkku.fi

Quarantine practices revised for those who have been vaccinated against COVID-19 and those who have already had the disease

Further information:  

Aleksi Yrttiaho
Director of Information Services
THL
[email protected]

Otto Helve
Chief Physician
THL
[email protected]